![](students/2008PIP212.jpg) | Registration No.: | PI/2008/XVI/212/P |
Name: | Baljinder Kaur Grewal |
---|
Connect at: | Linkedin |
---|
Ph.D. Thesis Title: |
---|
Computer Aided Drug Design of Protein Kinase Beta-II |
Research: 11 |
---|
Grewal BK, Bhat J, Sobhia ME. Molecular dynamics approach to probe PKCβII-ligand interactions and influence of crystal water molecules on these interactions. Expert Opinion on Therapeutic Targets 2015, 19: 13-23. |
Grewal BK, Krishnan RV, Sobhia ME. Structural basis of conformational variance in phosphorylated and non-phosphorylated states of PKCβII. Proteins: Structure, Function, and Bioinformatics 2014, 82: 1332-1347. |
Patro NM, Sultana A, Terao K, Nakata D, Jo A, Urano A, Ishida Y, Gorantla RN, Pandit V, Devi K, Rohit S, Grewal BK, Sobhia ME, Suresh A, Ekbote VK and Suresh S. Comparison and correlation of in vitro, in vivo and in silico evaluations of alpha, beta and gamma cyclodextrin complexes of curcumin. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2014, 78: 471-483. |
Grewal BK and Sobhia ME. Scaffold Hopping for Identification of Novel PKCβII Inhibitors Based on Ligand and Structural Approaches, Virtual Screening and Molecular Dynamics Study. Combinatorial Chemistry & High Throughput Screening 2013, 17: 2-11. |
Sobhia ME, Grewal BK, Ml SP, Patel J, Kaur A, Haokip T and Kokkula A. Protein kinase C inhibitors: a patent review (2008 - 2009). Expert Opinion on Therapeutic Patents 2013, 23: 1297-1315. |
Sobhia ME, Grewal BK, Paul ML, Patel J, Kaur A, Haokip T and Kokkula A. Protein kinase C inhibitors: a patent review (2010 - present). Expert Opinion on Therapeutic Patents 2013, 23: 1451-1468. |
Grewal BK and Sobhia ME. Identification of specific features of inhibition of PKCβII and its potential lead by shape-based virtual screening and molecular docking studies. Bioorganic & Medicinal Chemistry Letters 2012, 22: 4672-4677. |
Grewal BK and Sobhia ME. Theoretical investigations on maleimide and its indolyl derivatives: rational drug design approach for PKC-βII inhibitors. Journal of Molecular Structure 2012, 1029: 35-44. |
Sobhia ME, Grewal BK, Bhat J, Rohit S and Punia V. Protein kinase C βII in diabetic complications: survey of structural, biological and computational studies. Expert Opinion on Therapeutic Targets 2012, 16: 325-344. |
Divya PS, Grewal BK and Sobhia ME. 2D and 3D QSAR analyses to predict favorable substitution sites in anilino-monoindolylmaleimides acting as PKCβII selective inhibitors. Medicinal Chemistry Research 2011, 20: 1188-1199. |
Kumar H, Kumar R, Grewal BK and Sobhia ME. Insights into the Structural Requirements of PKCβII Inhibitors Based on HQSAR and CoMSIA Analyses. Chemical Biology & Drug Design 2011, 78: 283-288. |